NCT01830530 - HIGH Altitude CArdiovascular REsearch in the ANDES | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

October 31, 2012

Conditions

HypertensionHigh Altitude

Interventions

DRUG

Telmisartan

Subjects treated with telmisartan 80 mg (1 capsule daily in the morning) plus nifedipine slow release 30 mg (1 capsule daily in the morning) combination

DRUG

Nifedipine

Subjects treated with telmisartan 80 mg (1 capsule daily in the morning) plus nifedipine slow release 30 mg (1 capsule daily in the morning) combination

DRUG

placebo

two tablets daily in the morning

Trial Locations (1)

Unknown

Universidad Peruana Cayetano Heredia, Lima